« Back
Home /
LGX-818(Encorafenib)

LGX-818(Encorafenib)

Item no.	DCC-DC7018-250mg
Manufacturer	DCChemicals
CASRN	1269440-17-6
Amount	250 mg
Quantity options	100 mg 10 mM x 1 mL in DMSO 1 g 250 mg
Category	Reagents & Chemicals Molecules
Type	Inhibitors
Applications	ELISA
Specific against	other
Purity	>98%
Smiles	ClC1C([H])=C(C(=C(C=1[H])C1C(C2C([H])=C([H])N=C(N=2)N([H])C([H])([H])[C@]([H])(C([H])([H])[H])N([H])C(=O)OC([H])([H])[H])=C([H])N(C([H])(C([H])([H])[H])C([H])([H])[H])N=1)F)N([H])S(C([H])([H])[H])(=O)=O
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	LGX 818; LGX-818,LGX818
Similar products	1269440-17-6
Available
Manufacturer - Applications	LGX818 is an orally available mutated BRaf V600E inhibitor(IC50=0.3 nM) with potential antineoplastic activity.
Storage Conditions	2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
Molecular Weight	540, 0107
Note	For research only, not for human use.
Chemical name	methylN-[(2S)-1-[[4-[3-[5-chloro-2-fluoro-3-(methanesulfonamido)phenyl]-1-propan-2-ylpyrazol-4-yl]pyrimidin-2-yl]amino]propan-2-yl]carbamate

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 250 mg

available

Delivery expected until 7/3/2025

Express Delivery: Save 3 days

Compare

Add to wishlist

Recommend by mail